Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
1984-8-2
|
pubmed:abstractText |
Seventeen patients with advanced and recurrent squamous cell cervical cancer were treated with a combination of cisplatin and bleomycin. One complete and nine partial responses were observed (53%). The median duration of response was 8 months and the median survival was 12.7 months (5 months for nonresponders). Response was documented, particularly in patients with nodal disease and lung metastases. No life-threatening toxic effects were reported. This combination appears to be as effective as other combinations, has low toxicity, is well-tolerated, and merits further study.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0361-5960
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
68
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
891-3
|
pubmed:dateRevised |
2006-4-24
|
pubmed:meshHeading |
pubmed-meshheading:6203640-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:6203640-Bleomycin,
pubmed-meshheading:6203640-Carcinoma, Squamous Cell,
pubmed-meshheading:6203640-Cisplatin,
pubmed-meshheading:6203640-Female,
pubmed-meshheading:6203640-Humans,
pubmed-meshheading:6203640-Lymphatic Metastasis,
pubmed-meshheading:6203640-Neoplasm Recurrence, Local,
pubmed-meshheading:6203640-Time Factors,
pubmed-meshheading:6203640-Uterine Cervical Neoplasms
|
pubmed:year |
1984
|
pubmed:articleTitle |
Combination chemotherapy with cisplatin and bleomycin in advanced cervical cancer.
|
pubmed:publicationType |
Journal Article
|